BG103631A - 2-aminosubstituted pyridines applied for the treatment of atherosclerosis and hyperlipoproteinaemia - Google Patents
2-aminosubstituted pyridines applied for the treatment of atherosclerosis and hyperlipoproteinaemiaInfo
- Publication number
- BG103631A BG103631A BG103631A BG10363199A BG103631A BG 103631 A BG103631 A BG 103631A BG 103631 A BG103631 A BG 103631A BG 10363199 A BG10363199 A BG 10363199A BG 103631 A BG103631 A BG 103631A
- Authority
- BG
- Bulgaria
- Prior art keywords
- aminosubstituted
- pyridines
- atherosclerosis
- treatment
- hyperlipoproteinaemia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19704243A DE19704243A1 (de) | 1997-02-05 | 1997-02-05 | Neue 2-Amino-substituierte Pyridine |
| PCT/EP1998/000362 WO1998034920A1 (de) | 1997-02-05 | 1998-01-23 | 2-amino-substituierte pyridine verwendbar zur behandlung von arteriosklerose und hyperlipoproteinemie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103631A true BG103631A (en) | 2000-11-30 |
Family
ID=7819326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103631A BG103631A (en) | 1997-02-05 | 1999-08-03 | 2-aminosubstituted pyridines applied for the treatment of atherosclerosis and hyperlipoproteinaemia |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973744A1 (cs) |
| JP (1) | JP2001510478A (cs) |
| KR (1) | KR20000070756A (cs) |
| CN (1) | CN1252057A (cs) |
| AU (1) | AU730109B2 (cs) |
| BG (1) | BG103631A (cs) |
| BR (1) | BR9807181A (cs) |
| CA (1) | CA2279636A1 (cs) |
| CZ (1) | CZ279299A3 (cs) |
| DE (1) | DE19704243A1 (cs) |
| HU (1) | HUP0001022A2 (cs) |
| ID (1) | ID24208A (cs) |
| IL (1) | IL131127A0 (cs) |
| NO (1) | NO993738L (cs) |
| NZ (1) | NZ337011A (cs) |
| PL (1) | PL334899A1 (cs) |
| SK (1) | SK104099A3 (cs) |
| TR (1) | TR199901857T2 (cs) |
| WO (1) | WO1998034920A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA006777B1 (ru) | 2001-06-22 | 2006-04-28 | Пфайзер Продактс Инк. | Фармацевтические композиции адсорбатов аморфного лекарственного средства |
| BR0210518A (pt) | 2001-06-22 | 2004-06-22 | Pfizer Prod Inc | Composições farmacêuticas de dispersões de drogas e polìmeros neutros |
| EP1469832B2 (en) | 2002-02-01 | 2016-10-26 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| EP1603554A1 (en) | 2003-03-17 | 2005-12-14 | Japan Tobacco Inc. | Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| CA2532931A1 (en) | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| EP1670446A2 (en) | 2003-09-26 | 2006-06-21 | Japan Tobacco Inc. | Method of inhibiting remnant lipoprotein production |
| DOP2005000123A (es) * | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | Inhibidores de cetp |
| WO2006032987A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Indoline compounds and their use in the treatment of arteriosclerosis |
| EP1844078B1 (en) | 2005-02-03 | 2016-09-28 | Bend Research, Inc | Pharmaceutical compositions with enhanced performance |
| US20100113473A1 (en) | 2008-10-30 | 2010-05-06 | Player Mark R | Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
-
1997
- 1997-02-05 DE DE19704243A patent/DE19704243A1/de not_active Withdrawn
-
1998
- 1998-01-23 JP JP53369198A patent/JP2001510478A/ja active Pending
- 1998-01-23 AU AU62123/98A patent/AU730109B2/en not_active Ceased
- 1998-01-23 PL PL98334899A patent/PL334899A1/xx unknown
- 1998-01-23 EP EP98904126A patent/EP0973744A1/de not_active Ceased
- 1998-01-23 ID IDW990821D patent/ID24208A/id unknown
- 1998-01-23 CN CN98803916A patent/CN1252057A/zh active Pending
- 1998-01-23 WO PCT/EP1998/000362 patent/WO1998034920A1/de not_active Application Discontinuation
- 1998-01-23 NZ NZ337011A patent/NZ337011A/en unknown
- 1998-01-23 TR TR1999/01857T patent/TR199901857T2/xx unknown
- 1998-01-23 KR KR1019997007015A patent/KR20000070756A/ko not_active Application Discontinuation
- 1998-01-23 IL IL13112798A patent/IL131127A0/xx unknown
- 1998-01-23 HU HU0001022A patent/HUP0001022A2/hu unknown
- 1998-01-23 BR BR9807181-5A patent/BR9807181A/pt not_active IP Right Cessation
- 1998-01-23 SK SK1040-99A patent/SK104099A3/sk unknown
- 1998-01-23 CZ CZ992792A patent/CZ279299A3/cs unknown
- 1998-01-23 CA CA002279636A patent/CA2279636A1/en not_active Abandoned
-
1999
- 1999-08-02 NO NO993738A patent/NO993738L/no not_active Application Discontinuation
- 1999-08-03 BG BG103631A patent/BG103631A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337011A (en) | 2001-04-27 |
| SK104099A3 (en) | 2000-01-18 |
| ID24208A (id) | 2000-07-13 |
| EP0973744A1 (de) | 2000-01-26 |
| IL131127A0 (en) | 2001-01-28 |
| NO993738L (no) | 1999-09-17 |
| AU6212398A (en) | 1998-08-26 |
| PL334899A1 (en) | 2000-03-27 |
| WO1998034920A1 (de) | 1998-08-13 |
| BR9807181A (pt) | 2000-01-25 |
| NO993738D0 (no) | 1999-08-02 |
| JP2001510478A (ja) | 2001-07-31 |
| CA2279636A1 (en) | 1998-08-13 |
| CZ279299A3 (cs) | 1999-11-17 |
| AU730109B2 (en) | 2001-02-22 |
| CN1252057A (zh) | 2000-05-03 |
| TR199901857T2 (xx) | 1999-10-21 |
| DE19704243A1 (de) | 1998-08-06 |
| HUP0001022A2 (hu) | 2000-09-28 |
| KR20000070756A (ko) | 2000-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL336580A1 (en) | Fine-molecular compounds useful in treating inflammatory diseases | |
| MY131014A (en) | Heterocyclic-fused pyridines | |
| TR199700213A2 (xx) | 2-Aril s�bstit�entli piridinler. | |
| IL130260A (en) | 3-thiocarbamoylpyrazole derivatives as pesticides | |
| BG104056A (en) | Triazole compounds and their use as dopamine-d3-ligands | |
| BG103631A (en) | 2-aminosubstituted pyridines applied for the treatment of atherosclerosis and hyperlipoproteinaemia | |
| ATE197897T1 (de) | Hautpflegemittel | |
| BG104812A (en) | New dihydropyrimidines | |
| MY118207A (en) | Cycloalkano-pyridines | |
| MY129973A (en) | Sulphonylbenzyl-substituted pyridones. | |
| BG101131A (en) | 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons | |
| BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
| MX9804597A (es) | Derivados de bencimidazol sustituidos por naftilo como anticoagulantes. | |
| BG101139A (en) | Heteroatoms-containing cyclopentanopyridyloxazolidinons | |
| BG103556A (en) | 3-pyridyl enantiomers and their application as analgetics | |
| MA24643A1 (fr) | Tetrahydro-naphtalenes substitues et composes analogues | |
| GEP20002187B (en) | Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation | |
| IL113450A (en) | Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby | |
| BG104232A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazozocyn-10-ols, method for their preparation and application as medicamentous forms | |
| DE58908290D1 (de) | Disubstituierte Pyridine. | |
| TR200003302T2 (tr) | Anti-astım, anti-alerjik, anti-enflamatuar, bağışıklık düzenleyici ve nöro-koruyucu etkiye sahip yeni 1,2,5-trisübstitüe edilmiş 1,2-dihidroindazol-3-onlar, bunların hazırlanması için işlem ve bunların ilaç olarak kullanımı. | |
| HUP9900621A3 (en) | 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives, process to prepare them and pharmaceuticals contg. the said compds. | |
| TR200003596T2 (tr) | Hipnotik beta-karbolin türevleri,hazırlanmaları için işlem ve tıbbi ürün olarak kullanımları | |
| SE9400524D0 (sv) | Energipreparat | |
| CA2063721A1 (fr) | Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae |